Clinical Trial Update: Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer [NA]

View source ↗

Summary

A clinical trial comparing imaging-guided versus cardiac biomarker-monitored HER2-directed therapy in HER2-positive breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Odense University Hospital | Conditions: Cardiotoxicity, HER2-positive Breast Cancer | NA | Status: RECRUITING